Safe Biologics

NOVEMBER 12, 2023

View the full webinar here or watch individual segments linked below. Financing additional research and development into existing treatments will be difficult to justify. View ASBM’s recent webinar on the IRA’s effects here. ASBM surveys of U.S. Read the full op-ed here. Missed last month’s ASBM Newsletter?

Biosimilars 130

Biosimilars Drug Pricing Packaging Labelling 130

Safe Biologics

DECEMBER 6, 2023

REMINDER: FDA Draft Guidance Would Remove Interchangeability Statement from Interchangeable Biosimilars Comments Due November 17th On September 15th, the Food and Drug Administration (FDA) released draft guidance removing the interchangeability statement from the product label/package insert. Watch clips from the webinar here.

Biosimilars 130

Biosimilars Packaging Labelling Drug Development 130

Pharma Marketing Network

MARCH 18, 2025

Unlike other industries, pharma marketers must understand drug development, regulatory requirements, and clinical trial data to craft effective messaging. Being aware of pharmaceutical advertising laws, fair balance requirements, and off-label promotion restrictions will prevent costly compliance mistakes.

Labelling 52

Labelling Communication Drug Development 52